imbruvica
janssen-cilag international nv - ibrutinib - lymphoma, mantle-cell; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, protein kinase inhibitors - imbruvica as a single agent is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl). imbruvica as a single agent or in combination with rituximab or obinutuzumab or venetoclax is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. imbruvica as a single agent or in combination with bendamustine and rituximab (br) is indicated for the treatment of adult patients with cll who have received at least one prior therapy. imbruvica as a single agent is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo immunotherapy. imbruvica in combination with rituximab is indicated for the treatment of adult patients with wm.
epitoram 25 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - topiramatum - tabletki powlekane - 25 mg
epitoram 50 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - topiramatum - tabletki powlekane - 50 mg
epitoram 100 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - topiramatum - tabletki powlekane - 100 mg
epitoram 200 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - topiramatum - tabletki powlekane - 200 mg
kwetaplex xr 50 mg tabletki o przedłużonym uwalnianiu
adamed pharma s.a. - quetiapini fumaras - tabletki o przedłużonym uwalnianiu - 50 mg
kwetaplex xr 200 mg tabletki o przedłużonym uwalnianiu
adamed pharma s.a. - quetiapini fumaras - tabletki o przedłużonym uwalnianiu - 200 mg
kwetaplex xr 400 mg tabletki o przedłużonym uwalnianiu
adamed pharma s.a. - quetiapini fumaras - tabletki o przedłużonym uwalnianiu - 400 mg
vortemyel 1 mg proszek do sporządzania roztworu do wstrzykiwań
alvogen pharma trading europe eood - bortezomibum - proszek do sporządzania roztworu do wstrzykiwań - 1 mg
vortemyel 3,5 mg proszek do sporządzania roztworu do wstrzykiwań
alvogen pharma trading europe eood - bortezomibum - proszek do sporządzania roztworu do wstrzykiwań - 3,5 mg